Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Acquisition

2 May 2006 10:25

Torex Retail PLC02 May 2006 TOREX RETAIL PLC ("Torex Retail" or "the Group") EXPANSION OF PETROLEUM ACTIVITIES WITH ACQUISITION OF LEADING UK SERVICE PROVIDER Torex Retail, an international market leader in the provision of innovative ITsolutions, is pleased to announce the acquisition of TQIPS Limited ("TQIPS"), aleading provider of project management and services to UK petroleum retailers. The initial consideration payable of £7.25 million is to be satisfied by theissue to the vendors of 7.25 million ordinary shares in Torex Retail. Furtherconsideration of up to £3.5 million will be payable to the vendors dependentupon the profitability of TQIPS in the two years ending 31 December 2007. Anyadditional consideration payable will be satisfied through the issue of TorexRetail ordinary shares. Application has been made to the London Stock Market for the 7,250,000 sharesissued on completion to be admitted to trading on AIM. It is expected thatadmission will occur on 5 May 2006. Brendan Kavanagh , Head of Worldwide Petroleum for Torex Retail, commented : "Strategically TQIPS is a very important acquisition and a natural expansion ofour petroleum retail business. TQIPS has an unrivalled reputation for serviceand completes our overall service offering to the Major Oil Companies and majorsupermarket chains. Their blue chip customer list including Tesco, Asda,Morrisons, BP and Texaco further strengthens our base in this market whichalready includes Jet, Esso, Shell, Somerfields, Maxol, Lakeside Group and alarge number of independent dealers." This acquisition positions us extremely well to win significantly more businessin this expanding sector, including our target of achieving major contract winsfor LUCAS Petroleum." Ends. For further information please contact: Torex Retail plc: +44 (0) 870 300 6061 Brendan Kavanagh , Head of Worldwide Petroleum Mark Pearman , Group Finance Director Citigate Dewe Rogerson: +44 (0) 20 7638 9571 Seb Hoyle This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Jan 20267:00 amRNSSecondary Trading Following Cancellation
7th Jan 20267:00 amRNSCancellation - Tissue Regenix Group Plc
22nd Dec 20254:08 pmRNSResult of General Meeting and Cancellation
22nd Dec 20254:08 pmRNSResult of General Meeting and Cancellation
17th Dec 20256:00 pmRNSTissue Regenix Group
8th Dec 20257:00 amRNSUpdate re. proposed cancellation of shares
4th Dec 20252:40 pmRNSProposed £17.5m CLN raise, cancellation of Trading
1st Dec 20257:00 amRNSFurther re. financial update and funding plans
7th Nov 20257:00 amRNSFinancial update and funding plans
22nd Oct 20253:29 pmRNSStatement re. Suspension
22nd Oct 20252:02 pmRNSSuspension - Tissue Regenix Group PLC
17th Oct 20257:00 amRNSCFO joins Board
16th Oct 20257:00 amRNSUpdate re. FY24 & H125 restatement & Board Changes
9th Oct 20257:00 amRNSHolding(s) in Company
6th Oct 20253:29 pmRNSHolding(s) in Company
3rd Oct 20253:01 pmRNSHolding(s) in Company
2nd Oct 20254:43 pmRNSHolding(s) in Company
1st Oct 20255:35 pmRNSHolding(s) in Company
30th Sep 20257:00 amRNSHalf-year Report
17th Sep 20257:00 amRNSNotice of Results
8th Sep 20257:01 amRNSHalf-Year Trading Update and Notice of Results
8th Sep 20257:00 amRNSBoard Changes
1st Aug 20257:00 amRNSDirectorate Change
23rd Jul 20251:52 pmRNSResult of AGM
4th Jul 20257:00 amRNSGrant of share options
27th Jun 20257:00 amRNSPosting of Annual Report & Notice of AGM
25th Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
9th Jun 20257:00 amRNSCE & UKCA certification for OrthoPure® XT
24th Apr 20259:38 amRNSForm 8.5 (EPT/NON-RI)- Tissue Regenix Group Plc
15th Apr 20259:23 amRNSForm 8.5 (EPT/NON-RI)
10th Apr 20259:09 amRNSForm 8.5 (EPT/NON-RI)
9th Apr 202510:45 amRNSForm 8.5 (EPT/NON-RI)
8th Apr 20257:00 amRNSConclusion of Strategic Review & Offer Period
7th Apr 20258:46 amRNSForm 8.5 (EPT/NON-RI)
1st Apr 20259:12 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20259:21 amRNSForm 8.5 (EPT/NON-RI)
27th Mar 20257:00 amRNSEuropean patent granted
25th Mar 20258:58 amRNSForm 8.5- Tissue Regenix Group Plc
21st Mar 20258:36 amRNSForm 8.5 (EPT/NON-RI)
20th Mar 20259:19 amRNSForm 8.5 (EPT/NON-RI)
19th Mar 20258:55 amRNSForm 8.5 (EPT/NON-RI)
18th Mar 20259:29 amRNSForm 8.5 (EPT/NON-RI)
18th Mar 20257:00 amRNSCompany update
12th Mar 20259:27 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20259:30 amRNSForm 8.5 (EPT/NON-RI)
6th Mar 20259:29 amRNSForm 8.5 (EPT/NON-RI)
5th Mar 20258:54 amRNSForm 8.5 (EPT/NON-RI)
4th Mar 20259:28 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 20259:21 amRNSForm 8.5 (EPT/NON-RI)
21st Feb 20258:56 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.